Literature DB >> 10547344

Hypermethylation of tumor suppressor genes in cancer.

J G Herman1.   

Abstract

Hypermethylation of tumor suppressor genes and other genes functionally important in the neoplastic process is a recently recognized process. This epigenetic process is characterized by loss of function of these genes associated with transcriptional loss in the absence of structural alterations. The growing list of genes inactivated by promoter region hypermethylation provide an opportunity to examine the patterns of inactivation of such genes and provide clues as to the roles these events play in the neoplastic process. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10547344     DOI: 10.1006/scbi.1999.0138

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  49 in total

1.  Aberrant methylation of the maspin promoter is an early event in human breast cancer.

Authors:  Bernard W Futscher; Megan M O'Meara; Christina J Kim; Margaret A Rennels; Di Lu; Lynn M Gruman; Richard E B Seftor; Mary J C Hendrix; Frederick E Domann
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

Review 2.  Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication.

Authors:  Shara N Pantry; Peter G Medveczky
Journal:  Semin Cancer Biol       Date:  2009-02-21       Impact factor: 15.707

Review 3.  Folate, DNA methylation, and mouse models of breast tumorigenesis.

Authors:  Joshua W Miller; Alexander D Borowsky; Teresa C Marple; Erik T McGoldrick; Lisa Dillard-Telm; Lawrence J T Young; Ralph Green
Journal:  Nutr Rev       Date:  2008-08       Impact factor: 7.110

4.  FAT4 hypermethylation and grade dependent downregulation in gastric adenocarcinoma.

Authors:  Maryam Pilehchian Langroudi; Novin Nikbakhsh; Ali Akbar Samadani; Sadegh Fattahi; Hassan Taheri; Shahryar Shafaei; Galia Amirbozorgi; Reza Pilehchian Langroudi; Haleh Akhavan-Niaki
Journal:  J Cell Commun Signal       Date:  2016-10-01       Impact factor: 5.782

5.  Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancer.

Authors:  Myoung Sook Kim; Cinthia Lebron; Jatin K Nagpal; Young Kwang Chae; Xiaofei Chang; Yiping Huang; Tony Chuang; Keishi Yamashita; Barry Trink; Edward A Ratovitski; Joseph A Califano; David Sidransky
Journal:  Biochem Biophys Res Commun       Date:  2008-03-17       Impact factor: 3.575

6.  Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer.

Authors:  Myoung Sook Kim; Joost Louwagie; Beatriz Carvalho; Jochim S Terhaar Sive Droste; Hannah Lui Park; Young Kwang Chae; Keishi Yamashita; Junwei Liu; Kimberly Laskie Ostrow; Shizhang Ling; Rafael Guerrero-Preston; Semra Demokan; Zubeyde Yalniz; Nejat Dalay; Gerrit A Meijer; Wim Van Criekinge; David Sidransky
Journal:  PLoS One       Date:  2009-08-07       Impact factor: 3.240

7.  Promoter methylation of E-cadherin in hepatocellular carcinomas and dysplastic nodules.

Authors:  Ghee Young Kwon; Byung Chul Yoo; Kwang Cheol Koh; Jae Won Cho; Won Sang Park; Cheol Keun Park
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

8.  Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase.

Authors:  Oddbjørn Straume; Johanna Smeds; Rajiv Kumar; Kari Hemminki; Lars Andreas Akslen
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

9.  Global effects of BKV infection on gene expression in human primary kidney epithelial cells.

Authors:  Johanna R Abend; Jonathan A Low; Michael J Imperiale
Journal:  Virology       Date:  2009-11-28       Impact factor: 3.616

10.  CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity.

Authors:  Benny J Evison; Rebecca A Bilardi; Francis C K Chiu; Gabriella Pezzoni; Don R Phillips; Suzanne M Cutts
Journal:  Nucleic Acids Res       Date:  2009-08-31       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.